News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,942 Results
Type
Article (218)
Company Profile (1)
Press Release (1723)
Section
Business (677)
Career Advice (1)
Deals (122)
Drug Delivery (7)
Drug Development (103)
FDA (17)
Job Trends (27)
News (911)
Policy (98)
Tag
Academia (3)
Alliances (226)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (6)
Approvals (18)
Autoimmune disease (6)
Best Places to Work (12)
BIOSECURE Act (18)
Biotechnology (1)
Cancer (8)
Cardiovascular disease (1)
Career advice (1)
CAR-T (3)
Cell therapy (11)
Clinical research (89)
Collaboration (14)
COVID-19 (8)
C-suite (3)
Data (10)
Diagnostics (16)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (187)
Editorial (1)
Events (160)
Executive appointments (6)
FDA (20)
Funding (5)
Gene therapy (1)
GLP-1 (8)
Government (27)
Healthcare (26)
Immunology and inflammation (3)
Immuno-oncology (1)
Infectious disease (8)
Inflammatory bowel disease (1)
Intellectual property (2)
IPO (63)
IRA (1)
Job creations (13)
Job search strategy (1)
JPM (1)
Layoffs (3)
Legal (9)
Lung cancer (1)
Manufacturing (32)
MASH (1)
Medical device (18)
Medtech (18)
Mergers & acquisitions (64)
Metabolic disorders (5)
Multiple sclerosis (4)
NASH (1)
Neuroscience (6)
NextGen: Class of 2026 (18)
Non-profit (2)
Obesity (3)
Opinion (5)
People (167)
Phase 1 (57)
Phase 2 (36)
Phase 3 (13)
Pipeline (28)
Policy (23)
Preclinical (8)
Radiopharmaceuticals (1)
Real estate (63)
Regulatory (74)
Reports (1)
Research institute (1)
Series A (1)
Series B (1)
Startups (39)
Supply chain (4)
Tariffs (1)
The Weekly (4)
Vaccines (2)
Venture capital (1)
Weight loss (2)
Date
Last 7 days (2)
Last 30 days (11)
Last 365 days (96)
2026 (16)
2025 (93)
2024 (127)
2023 (113)
2022 (218)
2021 (205)
2020 (159)
2019 (116)
2018 (132)
2017 (117)
2016 (97)
2015 (117)
2014 (76)
2013 (60)
2012 (43)
2011 (38)
2010 (48)
Location
Africa (2)
Asia (963)
Australia (13)
California (26)
Canada (2)
China (65)
Europe (144)
Florida (3)
Illinois (1)
India (2)
Japan (1)
Maryland (1)
Massachusetts (17)
New Jersey (19)
New York (1)
North Carolina (1)
Northern California (17)
Ohio (2)
Pennsylvania (4)
South America (1)
Southern California (5)
Texas (1)
United States (77)
Utah (1)
Washington D.C. (3)
1,942 Results for "wuxi nextcode".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Press Releases
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
January 29, 2026
·
4 min read
Press Releases
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
January 5, 2026
·
3 min read
Press Releases
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
January 26, 2026
·
5 min read
Press Releases
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
January 15, 2026
·
9 min read
Press Releases
WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure
December 24, 2025
·
3 min read
Press Releases
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry
November 20, 2025
·
5 min read
Press Releases
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year
October 10, 2025
·
3 min read
Press Releases
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
October 28, 2025
·
3 min read
Press Releases
WuXi Biologics Reports Solid 2025 Interim Results
August 20, 2025
·
16 min read
1 of 195
Next
